Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study With High Doses of Chemotherapy, Radiotherapy and Consolidation Therapy With Ciclofosfamide and Anticyclooxygenase 2, for the Metastatic Ewing Sarcoma

NCT02727387 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT02727387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02727387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study With High Doses of Chemotherapy, Radiotherapy and Consolidation Therapy With Ciclofosfamide and Anticyclooxygenase 2, for the Metastatic Ewing Sarcoma
Lead sponsor
Italian Sarcoma Group
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2009
Completion date
April 29, 2022
Enrollment
155 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

ewing's sarcoma (es)